![]() |
|
|
Vol. 296, Issue 2, 458-463, February 2001
Department of Pharmacology and Anesthesiology, University of
Padova, Padova, Italy (S.B., L.T., L.C., S.L., G.C.); and
Department of Physiology, University of Maryland School of Medicine,
Baltimore, Maryland (V.G.)
Norbormide (NRB) is a selective vasoconstrictor agent of the rat small
vessels. The mechanisms underlying the selective vasoconstrictor effect
of NRB are unknown. To investigate whether phospholipase C (PLC)
signaling pathway plays a role in NRB-induced vasoconstriction, we
performed experiments in NRB-contracted tissues, namely, rat caudal
arteries (RCA) and smooth muscle cells derived from rat mesenteric
arteries (MVSMCs). An NRB-insensitive vessel, namely rat aorta (RA),
served as a control tissue. In RCA and RA we measured either isometric
tension or formation of inositol phosphates (IPs), the latter taken as
an index of PLC activation. In MVSMCs, we measured intracellular free
calcium concentration ([Ca2+]cyt). In the
presence of external Ca2+, NRB (2-50 µM) stimulated IPs
formation in RCA but not in RA, and increased
[Ca2+]cyt in MVSMCs. In the absence of
external Ca2+, NRB (50 µM) increased IPs formation in RCA
but was unable to increase [Ca2+]cyt in
MVSMCs. In RCA, in the presence of external Ca2+,
NRB-induced contraction was inhibited by calphostin C (0.2-1 µM), an
inhibitor of protein kinase C (PKC), and by SK&F 96365 (30 µM), an
inhibitor of the store-operated calcium channels, but was poorly
affected by verapamil, an L-type calcium channel blocker. However,
verapamil was much more effective when external Ca2+ was
substituted by Sr2+. These results suggest that NRB elicits
its tissue and species-selective vasoconstrictor effect by stimulating
PLC-PKC pathway and increasing Ca2+ influx through both
verapamil-sensitive and -insensitive calcium channels. Ca2+
release from sarcoplasmic reticulum seems not involved in NRB vasoconstriction.